×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Scopelianos Angelo

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
AXGNAxogen, Inc.Scopelianos AngeloChief R&D OfficerMar 21, 2024Sale$7.686,88152,84657,994Mar 25, 2024, 09:37 PM
AXGNAxogen, Inc.Scopelianos AngeloChief R&D OfficerOct 13, 2023Option Exercise$4.041,4035,66836,969Oct 13, 2023, 08:28 PM
AXGNAxogen, Inc.Scopelianos AngeloChief R&D OfficerMar 16, 2023Option Exercise$8.273,90732,31137,512Mar 20, 2023, 06:27 PM
AXGNAxogen, Inc.Scopelianos AngeloChief R&D OfficerDec 27, 2022Option Exercise$9.442862,70025,958Dec 29, 2022, 08:40 PM
AXGNAxogen, Inc.Scopelianos AngeloChief R&D OfficerJul 19, 2022Option Exercise$8.406575,51925,094Jul 20, 2022, 04:04 PM
AXGNAxogen, Inc.Scopelianos AngeloChief R&D OfficerMar 16, 2022Option Exercise$7.972,77022,07720,180Mar 18, 2022, 04:11 PM
AXGNAxogen, Inc.Scopelianos AngeloChief R&D OfficerFeb 15, 2022Option Exercise$8.424003,36811,950Feb 17, 2022, 04:11 PM
AXGNAxogen, Inc.Scopelianos AngeloChief R&D OfficerDec 27, 2021Option Exercise$9.742862,78610,984Dec 29, 2021, 04:31 PM
AXGNAxogen, Inc.Scopelianos AngeloChief R&D OfficerJul 20, 2021Option Exercise$19.2063712,23010,120Jul 21, 2021, 04:14 PM
AXGNAxogen, Inc.Scopelianos AngeloChief R&D OfficerFeb 17, 2021Option Exercise$18.714067,5967,046Feb 18, 2021, 05:27 PM
AXGNAxogen, Inc.Scopelianos AngeloVP Research & DevelopmentDec 29, 2020Sale$17.8156710,0985,529Dec 30, 2020, 11:55 AM
AXGNAxogen, Inc.Scopelianos AngeloVP Research & DevelopmentFeb 18, 2020Option Exercise$14.683945,7842,249Feb 20, 2020, 04:17 PM